Nevertheless, Manchester’s life sciences cluster has bounced back and evolved following AstraZeneca’s departure, Sheppard ...
Canary Wharf Group has joined forces with science facility developer Kadans on the project, which will kick off with the construction of a 22 storey, 750,000 sq. ft. building dedicated to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback